Research Analysts Issue Forecasts for Synergy CHC Q1 Earnings

Synergy CHC Corp. (NASDAQ:SNYR) – Investment analysts at Ascendiant Capital Markets issued their Q1 2026 EPS estimates for shares of Synergy CHC in a research report issued to clients and investors on Monday, April 13th. Ascendiant Capital Markets analyst E. Woo anticipates that the company will post earnings of $0.03 per share for the quarter. Ascendiant Capital Markets currently has a “Buy” rating and a $5.50 target price on the stock. The consensus estimate for Synergy CHC’s current full-year earnings is $0.36 per share. Ascendiant Capital Markets also issued estimates for Synergy CHC’s Q2 2026 earnings at $0.04 EPS, Q3 2026 earnings at $0.05 EPS, Q4 2026 earnings at $0.02 EPS, FY2026 earnings at $0.13 EPS, Q1 2027 earnings at $0.06 EPS, Q2 2027 earnings at $0.06 EPS, Q3 2027 earnings at $0.07 EPS, Q4 2027 earnings at $0.05 EPS and FY2027 earnings at $0.24 EPS.

Synergy CHC (NASDAQ:SNYR) last issued its quarterly earnings data on Wednesday, April 1st. The company reported ($1.54) earnings per share (EPS) for the quarter. Synergy CHC had a negative return on equity of 19.51% and a negative net margin of 42.59%.The firm had revenue of $6.07 million during the quarter.

Separately, Weiss Ratings downgraded shares of Synergy CHC from a “hold (c-)” rating to a “sell (d-)” rating in a research report on Friday, April 10th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $6.25.

Synergy CHC Price Performance

Shares of Synergy CHC stock opened at $0.52 on Monday. The firm’s 50 day moving average price is $1.20 and its 200-day moving average price is $1.75. Synergy CHC has a 52-week low of $0.42 and a 52-week high of $4.00. The company has a market cap of $6.02 million, a P/E ratio of -0.49 and a beta of 2.92.

Institutional Trading of Synergy CHC

Several large investors have recently bought and sold shares of the stock. DRW Securities LLC purchased a new stake in Synergy CHC during the 4th quarter worth approximately $36,000. Geode Capital Management LLC grew its position in Synergy CHC by 29.9% during the 4th quarter. Geode Capital Management LLC now owns 36,038 shares of the company’s stock worth $67,000 after purchasing an additional 8,288 shares during the last quarter. Virtu Financial LLC purchased a new stake in Synergy CHC during the 3rd quarter worth approximately $38,000. Heartland Advisors Inc. purchased a new stake in Synergy CHC during the 3rd quarter worth approximately $1,342,000. Finally, Warberg Asset Management LLC purchased a new stake in Synergy CHC during the 3rd quarter worth approximately $82,000.

Key Synergy CHC News

Here are the key news stories impacting Synergy CHC this week:

• Positive Sentiment: Ascendiant reiterates a “Buy” rating and a $5.50 price target for SNYR — a clear positive signal that can attract demand from growth‑oriented investors. MarketBeat Coverage
• Positive Sentiment: The firm provided a multi‑quarter roadmap showing improving EPS: Q1–Q4 2026 (mix of $0.03–$0.02), FY2026 $0.13, then rising through 2027 to FY2027 $0.24 — this projected upward trend supports investor expectations for recovery. MarketBeat Coverage
• Neutral Sentiment: Ascendiant issued separate notes with quarter‑level EPS estimates (Q1–Q4 2026 and Q1–Q4 2027); the repetition is informational but does not add new strategic detail beyond the consolidated outlook. MarketBeat Coverage
• Negative Sentiment: Ascendiant’s FY2026 ($0.13) and FY2027 ($0.24) EPS forecasts are materially below the cited consensus full‑year estimate of $0.36, which could limit credibility of upside and signal a more conservative view on near‑term profitability. MarketBeat Coverage
• Negative Sentiment: Fundamentals remain risky: small market cap, recent quarterly loss (last reported EPS was negative) and wide trading range suggest high volatility and execution risk despite the analyst coverage. Investors should weigh the Buy rating and price target against these company‑specific risks. MarketBeat Coverage

About Synergy CHC

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.